NanoVibronix reports positive UroShield study; 1/3 of patients saw fewer blockages

ENvue Medical, Inc.

Approximately one-third of patients reported reduction in catheter blockages and need for unscheduled changes.
Qualitative data showed favorable opinions from majority of participants in the independent study.
Study published on ScienceDirect; investigated UroShield's effect on CAUTI and catheter blockage.
CEO highlights market opportunities and need for alternatives to antibiotics in long-term catheter care.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.